A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Yohimbine
Ethenzamide
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Ethenzamide.
Yohimbine
Guacetisal
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Guacetisal.
Yohimbine
Proglumetacin
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Proglumetacin.
Yohimbine
Propyphenazone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Propyphenazone.
Yohimbine
Tenidap
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Tenidap.
Yohimbine
Lonazolac
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Lonazolac.
Yohimbine
Nifenazone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Nifenazone.
Yohimbine
Difenpiramide
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Difenpiramide.
Yohimbine
Alminoprofen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Alminoprofen.
Yohimbine
Bumadizone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Bumadizone.
Yohimbine
Suxibuzone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Suxibuzone.
Yohimbine
Fentiazac
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Fentiazac.
Yohimbine
Alclofenac
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Alclofenac.
Yohimbine
Tinoridine
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Tinoridine.
Yohimbine
Ebselen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Ebselen.
Yohimbine
Indobufen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Indobufen.
Yohimbine
Nitroaspirin
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Nitroaspirin.
Yohimbine
Polmacoxib
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Polmacoxib.
Yohimbine
Flunixin
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Flunixin.
Yohimbine
Tepoxalin
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Tepoxalin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3